IGF-I treatment of patients with Laron syndrome

3Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In this chapter we describe pharmacokinetic studies with IGF-I in children, once biosynthetic IGF-I became available. The biochemical and hormonal effects upon short-term administration and growth promoting effects upon long-term treatment are summarized. It was found that IGF-I is a potent anabolic and growth stimulating hormone. Our results are compared with those obtained by other investigators. © Springer-Verlag Berlin Heidelberg 2011.

Cite

CITATION STYLE

APA

Laron, Z. (2011). IGF-I treatment of patients with Laron syndrome. In Laron Syndrome - From Man to Mouse: Lessons from Clinical and Experimental Experience (pp. 343–380). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-642-11183-9_42

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free